Contact
Please use this form to send email to PR contact of this press release:
BioFactura Announces Activation of a $15.9M Contract Option for its Smallpox Biodefense Therapeutic
TO:
Jeffrey Hausfeld MD,MBA
BioFactura, Inc.
+1 301-792-8601